2/5
08:30 am
rnxt
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
Low
Report
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
2/4
08:30 am
rnxt
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
Medium
Report
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
1/31
07:46 am
rnxt
RenovoRx (NASDAQ:RNXT) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
Medium
Report
RenovoRx (NASDAQ:RNXT) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
1/28
08:30 am
rnxt
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting
Low
Report
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting
1/20
08:30 am
rnxt
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
Medium
Report
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
1/18
08:21 am
rnxt
Loss-Making RenovoRx, Inc. (NASDAQ:RNXT) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Medium
Report
Loss-Making RenovoRx, Inc. (NASDAQ:RNXT) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
1/14
08:30 am
rnxt
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
Low
Report
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
1/8
08:30 am
rnxt
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
Medium
Report
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
5/15/2025
04:05 pm
rnxt
renovorx, inc.
IN-LINE
Report
5.4%
renovorx, inc.
2/6
07:01 am
rnxt
Form 8-K RenovoRx, Inc. For: Feb 06
Low
Report
Form 8-K RenovoRx, Inc. For: Feb 06
1/30
12:14 pm
rnxt
Form SCHEDULE 13G/A RenovoRx, Inc. Filed by: HIRSCHMAN ORIN
High
Report
Form SCHEDULE 13G/A RenovoRx, Inc. Filed by: HIRSCHMAN ORIN
1/22
07:00 am
rnxt
Form 4 RenovoRx, Inc. For: Jan 21 Filed by: Agah Ramtin
Low
Report
Form 4 RenovoRx, Inc. For: Jan 21 Filed by: Agah Ramtin
1/5
07:00 am
rnxt
Form 4 RenovoRx, Inc. For: Dec 31 Filed by: Agah Ramtin
High
Report
Form 4 RenovoRx, Inc. For: Dec 31 Filed by: Agah Ramtin
1/2
05:00 pm
rnxt
Form 4 RenovoRx, Inc. For: Dec 30 Filed by: Agah Ramtin
High
Report
Form 4 RenovoRx, Inc. For: Dec 30 Filed by: Agah Ramtin
1/2
04:11 pm
rnxt
Form 8-K RenovoRx, Inc. For: Jan 02
High
Report
Form 8-K RenovoRx, Inc. For: Jan 02
12/22
07:00 am
rnxt
Form 4 RenovoRx, Inc. For: Dec 18 Filed by: Bagai Shaun
Medium
Report
Form 4 RenovoRx, Inc. For: Dec 18 Filed by: Bagai Shaun
12/19
07:00 am
rnxt
Form 4 RenovoRx, Inc. For: Dec 17 Filed by: Bagai Shaun
Medium
Report
Form 4 RenovoRx, Inc. For: Dec 17 Filed by: Bagai Shaun
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register